Results 61 to 70 of about 376,416 (350)

Personalized Regenerative Medicine

Acta Medica Iranica, 2017
Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data.
Babak Arjmand, Parisa Goodarzi, Fereshteh Mohamadi-Jahani, Khadijeh Falahzadeh, Bagher Larijani   +4 more
doaj  

Current status of regenerative medicine in osteoarthritis: stem cells, exosomes, and genes

Bone & Joint Research, 2021
The high prevalence of osteoarthritis (OA), as well as the current lack of disease-modifying drugs for OA, has provided a rationale for regenerative medicine as a possible treatment modality for OA treatment.
Gun-Il Im
doaj   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Transforming healthcare through regenerative medicine [PDF]

, 2016
Regenerative medicine therapies, underpinned by the core principles of rejuvenation, regeneration and replacement, are shifting the paradigm in healthcare from symptomatic treatment in the 20th century to curative treatment in the 21st century.
A Atala, A Gonfiotti, A O’Dowd, A Soto-Gutierrez, A Trounson, A Trounson, A Tsukamoto, Ayesha Al-Sabah, BK Chacko, C Mason, CE Ford, CR Alta, DN Galbraith, F Progatzky, G Orlando, G Ram-Liebig, G Vogel, H Landecker, HC Ott, Iain S. Whitaker, JA Thomson, JL Christensen, K Takahashi, KR Matthews, LC Stevens, ME Sunderland, MH Lee, MJ Evans, MK Carpenter, P Kemp, P Macchiarini, R Calne, T Bubela, TJ Nelson, W Haseltine, Wendy R. Francis, Y Cao, Zita M. Jessop   +37 more
core   +1 more source

Materials in Regenerative Medicine [PDF]

Advanced Materials, 2009
V. Prasad Shastri is the Professor of Biofunctional Macromolecular Chemistry, the BIOSS Professor of Cell Signalling Microenvironments, and one of the core faculties of the BIOSS Excellence Cluster at the Albert-Ludwigs University of Freiburg, Germany. He is internationally recognized for his contributions in biodegradable polymers, bone and cartilage ...
Shastri, V. Prasad, Lendlein, Andreas
openaire   +4 more sources

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

Kidney regeneration and repair after transplantation [PDF]

, 2013
PURPOSE OF REVIEW: To briefly show which are the mechanisms and cell types involved in kidney regeneration and describe some of the therapies currently under study in regenerative medicine for kidney transplantation.
Cruzado, J.M., Flaquer, M. (Maria), Franquesa, M. (Marcella), Grinyo, J. (Josep)   +3 more
core   +1 more source

Recent Developments of Silk-Based Scaffolds for Tissue Engineering and Regenerative Medicine Applications: A Special Focus on the Advancement of 3D Printing

Biomimetics, 2023
Regenerative medicine has received potential attention around the globe, with improving cell performances, one of the necessary ideas for the advancements of regenerative medicine.
Asma Musfira Shabbirahmed, Rajkumar Sekar, Levin Anbu Gomez, Medidi Raja Sekhar, Samson Prince Hiruthyaswamy, Nagaraj Basavegowda, Prathap Somu   +6 more
doaj   +1 more source

Regenerative Medicine and the Gut [PDF]

Gastroenterology, 2011
Regenerative medicine refers to the process of creating functional tissues to augment or replace organs lost to age, disease, damage, or congenital defects1. Several technologies brought to bear on this challenge have had notable results. In gastroenterology and hepatology in particular, recent publications have demonstrated pre-clinical success in the
Johann Peterson, Pankaj J. Pasricha
openaire   +3 more sources

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source